Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weidmann

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
British Journal of Haematology|February 13, 2001
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chainsS Boehrer, T Hinz, D Schui, et al.
Nature|September 22, 1994
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiologyB Conrad, E Weidmann, G Trucco, et al.
International Journal of Clinical Pharmacy|February 9, 2024
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical PharmacyFrancesca Wirth, Cathal A Cadogan, Daniela Fialová, et al.
International Journal of Clinical Pharmacy|March 2, 2024
Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical PharmacyFrancesca Wirth, Cathal A Cadogan, Daniela Fialová, et al.
Cancer|July 15, 1993
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trialsU Keilholz, C Scheibenbogen, W Tilgen, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
COPD|July 28, 2025
Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP)Ivana Tadic, Daniela Fialová, Ankie Hazen, et al.
International Journal of Clinical Pharmacy|February 6, 2026
Correction: Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
British Journal of Haematology|February 13, 2001
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chainsS Boehrer, T Hinz, D Schui, et al.
Nature|September 22, 1994
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiologyB Conrad, E Weidmann, G Trucco, et al.
International Journal of Clinical Pharmacy|February 9, 2024
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical PharmacyFrancesca Wirth, Cathal A Cadogan, Daniela Fialová, et al.
International Journal of Clinical Pharmacy|March 2, 2024
Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical PharmacyFrancesca Wirth, Cathal A Cadogan, Daniela Fialová, et al.
Cancer|July 15, 1993
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trialsU Keilholz, C Scheibenbogen, W Tilgen, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
COPD|July 28, 2025
Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP)Ivana Tadic, Daniela Fialová, Ankie Hazen, et al.
International Journal of Clinical Pharmacy|February 6, 2026
Correction: Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.
Pageof 12